ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2017. The put-call ratio across all filers is 3.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,618,000 | -56.9% | 62,245 | -38.4% | 0.26% | -66.8% |
| Q3 2020 | $3,758,000 | -27.5% | 101,099 | -0.0% | 0.79% | -28.7% |
| Q2 2020 | $5,187,000 | +85.3% | 101,101 | +13.9% | 1.10% | +30.5% |
| Q1 2020 | $2,799,000 | -62.2% | 88,760 | -28.6% | 0.84% | -44.5% |
| Q4 2019 | $7,408,000 | +355.6% | 124,231 | +452.7% | 1.52% | +45.9% |
| Q1 2018 | $1,626,000 | +118.0% | 22,478 | +98.4% | 1.04% | +72.7% |
| Q4 2017 | $746,000 | +65.8% | 11,327 | +26.1% | 0.60% | +30.5% |
| Q3 2017 | $450,000 | -14.3% | 8,980 | -20.8% | 0.46% | -29.3% |
| Q2 2017 | $525,000 | – | 11,335 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |